Last update 30 Aug 2025

ALXN1910

Overview

Basic Info

Drug Type
Enzyme
Synonyms
ALXN 1910, ALXN-1910, ALXN1910
Target
TNSALP
Action
inhibitors
Mechanism
TNSALP inhibitors(Alkaline phosphatase, tissue-nonspecific isozyme inhibitors)
Therapeutic Areas
Endocrinology and Metabolic DiseaseSkin and Musculoskeletal Diseases
Active Indication-
Inactive Indication
Bone Diseases, Metabolic
Originator Organization
Alexion Pharmaceuticals, Inc.Alexion Pharmaceuticals, Inc.
Active Organization-
Inactive Organization
Alexion Pharmaceuticals, Inc.Alexion Pharmaceuticals, Inc.
License Organization-
Drug Highest PhaseDiscontinuedPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with ALXN1910
NCT05307978
/ CompletedPhase 1
A Phase 1, Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study of Subcutaneously and Intravenously Administered ALXN1910 in Healthy Adult Participants
100 Clinical Results associated with ALXN1910
Login to view more data
100 Translational Medicine associated with ALXN1910
Login to view more data
100 Patents (Medical) associated with ALXN1910
Login to view more data
100 Deals associated with ALXN1910
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Bone Diseases, MetabolicPhase 1
United Kingdom
Alexion Pharmaceuticals, Inc.Alexion Pharmaceuticals, Inc.
12 Apr 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT05307978 (CTgov)
Phase 1
-
48
(Cohort 1- 5 mg)
uekgwmeuzm = cfqezosmwp tkmajgksxa (pzdxeaysta, xmdskvdubj - fqtnrothmf)
View more
-
27 Feb 2025
(Cohort 2- 15 mg SC)
uekgwmeuzm = pgyxfyazac tkmajgksxa (pzdxeaysta, ihennghecq - zloahzdmas)
View more
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free